Preparation for a first-in-man lentivirus trial in cystic fibrosis patients

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients

Bibliographic Details
Main Authors:	Griesenbach, U, Alton, E, Beekman, J, Boyd, C, Davies, J, Davies, L, Dekkers, J, Gill, D, Hasegawa, M, Higgins, T, Hironaka, T, Inoue, M, Hyde, S, Innes, A, Pringle, I, Pytel, K, Sumner-Jones, S, Tsugumine, S, Wasowicz, M
Format:	Conference item
Published:	Elsevier 2016

Similar Items

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
by: Alton, E, et al.
Published: (2016)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
by: Hyde, S, et al.
Published: (2015)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
by: Davies, G, et al.
Published: (2011)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
by: Alton, E, et al.
Published: (2013)

Exploring the mechanisms of macrolides in cystic fibrosis.
by: Equi, A, et al.
Published: (2006)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
by: Davies, J, et al.
Published: (2009)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
by: Sergijenko, A, et al.
Published: (2020)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
by: Griesenbach, U, et al.
Published: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
by: Pringle, I, et al.
Published: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
by: Pringle, I, et al.
Published: (2012)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
by: Griesenbach, U, et al.
Published: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
by: Griesenbach, U, et al.
Published: (2012)

Towards a first-in-human trial with a pseudotyped lentivirus
by: Alton, EW, et al.
Published: (2020)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
by: Alton, E, et al.
Published: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
by: Alton, E, et al.
Published: (2013)

Clinical improvement in cystic fibrosis following anti-tumourous chemotherapy.
by: Eisen, S, et al.
Published: (2004)

A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2015)

Emerging gene therapies for cystic fibrosis
by: Miah, K, et al.
Published: (2019)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
by: McLachlan, G, et al.
Published: (2011)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
by: Pringle, I, et al.
Published: (2009)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)

A poly-functional gene delivery system for cystic fibrosis
by: Montier, T, et al.
Published: (2017)

Moving lentiviral-based gene therapy into a first-in-man CF trial
by: Griesenbach, D, et al.
Published: (2015)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
by: Palau, H, et al.
Published: (2019)

Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways
by: Chotirmall, Sanjay Haresh, et al.
Published: (2017)

Cystic Fibrosis in Malaysian Children
by: Norzila, M.Z., et al.
Published: (2005)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
by: Lund-Palau, H, et al.
Published: (2018)

Gene therapy for cystic fibrosis: from basic research to clinical impact
by: Hyde, S
Published: (2013)

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
by: Hyde, S
Published: (2013)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
by: Hyde, S, et al.
Published: (1993)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
by: Paul-Smith, M, et al.
Published: (2017)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
by: Sinadinos, A, et al.
Published: (2020)

Sleep phase delay in cystic fibrosis: a potential new manifestation of cystic fibrosis transmembrane regulator dysfunction
by: Jensen, J, et al.
Published: (2017)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
by: Lund-Palau, H, et al.
Published: (2018)

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
by: Hyde, S, et al.
Published: (2000)

Microbial interactions in the cystic fibrosis airway
by: Granchelli, AM, et al.
Published: (2018)